Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

The World Marrow Donor Association (WMDA): its goals and activities

Bone Marrow Transplantation volume 32, pages 121–124 (2003)Cite this article

Summary:

The major goal of the World Marrow Donor Association (WMDA) is to facilitate the transfer of hematopoietic cells for transplantation purposes across international borders. It also has the goal of establishing guidelines on ethical, technical, medical, and financial aspects that concern the donor and donor-cell transfer. It has a Board and five Working Groups, namely the Donor Registry Working Group, the Quality Assurance Group, the Ethic Working Group, the Finance Working Group, and the Clinical Working Group. It has three types of membership, that is, full organizational membership, nonvoting organizational membership, and individual corresponding membership. Current important projects are speeding up the search process, accreditation of registries and collecting information about severe adverse effects in donors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. The Executive Committee of the World Marrow Donor Association. Special report: Bone marrow transplants using volunteer donors – recommendations and requirements for a standardized practice throughout the world. Bone Marrow Transplant 1992; 10: 287–291.

  2. Goldman JM, Cleaver S, Warren P . World Marrow Donor Association: a progress report. Bone Marrow Transplant 1994; 13: 689–691.

    CAS  Google Scholar 

  3. Gahrton G . Goals and activities of the WMDA. World Marrow Donor Association. Int J Hematol 2002; 76 (Suppl. 1): 384–385.

    Article  Google Scholar 

  4. Thomas E, Storb R, Clift RA et al. Bone-marrow transplantation (first of two parts). N Engl J Med 1975; 292: 832–843.

    Article  CAS  Google Scholar 

  5. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895–902.

    Article  CAS  Google Scholar 

  6. Hansen J, McCullough J . Alternative donors – unrelated donor BMT. In: Champlin RE, Gale RP (eds). New Strategies in Bone Marrow Transplantation. Wiley-Liss: New York, 1991, pp 453–457.

    Google Scholar 

  7. Goldman JM . A special report: bone marrow transplants using volunteer donors – recommendations and requirements for a standardized practice throughout the world – 1994 update. The WMDA Executive Committee. Blood 1994; 84: 2833–2839.

    CAS  Google Scholar 

  8. Hurley CK, Wade JA, Oudshoorn M et al. Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: report from The World Marrow Donor Association. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Bone Marrow Transplant 1999; 24: 119–121.

    Article  CAS  Google Scholar 

  9. Cleaver SA, Warren P, Kern M et al. Donor work-up and transport of bone marrow – recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA). Bone Marrow Transplant 1997; 20: 621–629.

    Article  CAS  Google Scholar 

  10. Hurley CK, Schreuder GM, Marsh SG, Lau M, Middleton D, Noreen H . The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. Tissue Antigens 1997; 50: 401–418.

    Article  CAS  Google Scholar 

  11. Hurley CK, Wade JA, Oudshoorn M et al. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Hum Immunol 1999; 60: 347–360.

    Article  CAS  Google Scholar 

  12. Schreuder GM, Hurley CK, Marsh SG et al. The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens 1999; 54: 409–437.

    Article  CAS  Google Scholar 

  13. Bakken R, van Walraven A, Egeland T on behalf of the Ethics Working Group of the World Marrow Donor Association. Donor commitment and patients needs. Bone Marrow Transplant 2003; submitted.

  14. Rosenmayr A, Hartwell L, Egeland T on behalf of the Ethics Working Group of the World Marrow Donor Association. Informed consent suggested procedures for informed consent for unrelated hematopoietic stem cell donors at various stages of recruitment, donor evaluation and donor workup. Bone Marrow Transplant 2003; 31: 531–537.

    Article  Google Scholar 

  15. Egeland T, Lie J, Persson U on behalf of the World Marrow Donor Association (WMDA) Ethics Working Group and Raymond J, and Müller C, WMDA Finance Working Group. Donor and liability insurance of donor registries, donor centers and collection centers. Bone Marrow Transplant 2003; submitted.

  16. Marry E, Oudshoorn M (eds). Donor Registries Annual Report 2001, 5th edn. WMDA: Netherlands, 2002.

    Google Scholar 

  17. Oudshoorn M (ed). Unrelated Cord Blood Registries/Banks. Annual Report 2001, 3rd edn. WMDA, NetCord: Netherlands, 2001.

    Google Scholar 

  18. Bensinger WI MP, Storer B, Clift R et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175–181.

    Article  Google Scholar 

  19. Gahrton G, Svensson H, Cavo M et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 2001; 113: 209–216.

    Article  CAS  Google Scholar 

  20. Gahrton G AJ, Bacigalupo A, Björkstrand B et al. An update of allogeneic transplantation with peripheral blood stem cells (PBSCT) as compared to bone marrow (BMT) in multiple myeloma. Bone Marrow Transplant 2001; 29 (Suppl. 2): S13.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden

    G Gahrton

  2. WMDA, Europdonor Foundation, Plesmanlaan, Leiden, The Netherlands

    J J van Rood & M Oudshoorn

Authors
  1. G Gahrton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J J van Rood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Oudshoorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

and The World Marrow Donor Association (WMDA)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gahrton, G., van Rood, J., Oudshoorn, M. et al. The World Marrow Donor Association (WMDA): its goals and activities. Bone Marrow Transplant 32, 121–124 (2003). https://doi.org/10.1038/sj.bmt.1704097

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704097

This article is cited by

Search

Advanced search

Quick links